CHI3L1 and Alzheimer disease: Compared to controls, YKL-40 mRNA levels were increased in the FC of AD cases at early (AD I-III, p < 0.05) and late (AD IV-VI and rpAD IV-VI, p < 0.001) neurofibrillary tangle Braak stages (Fig. 4a).